Acadian Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-240
Closed -$39K 2099
2026
Q1
$39K Sell
240
-3,365
-93% -$517K ﹤0.01% 1882
2025
Q4
$626K Buy
3,605
+1,402
+64% +$256K ﹤0.01% 1244
2025
Q3
$315K Buy
2,203
+1,049
+91% +$129K ﹤0.01% 1313
2025
Q2
$116K Sell
1,154
-562
-33% -$43K ﹤0.01% 1380
2025
Q1
$130K Sell
1,716
-289
-14% -$22.1K ﹤0.01% 1314
2024
Q4
$138K Sell
2,005
-7,477
-79% -$538K ﹤0.01% 1313
2024
Q3
$692K Buy
+9,482
New +$700K ﹤0.01% 1006

Other funds holding INSM

Acadian Asset Management's INSM Position: Q2 2026 in Review

Acadian Asset Management sold out of Insmed (INSM) in Q2 2026, closing a stake of 240 shares — an estimated $39K sold.

Acadian Asset Management first reported a position in INSM in Q3 2024 and held it in 7 quarters. The position peaked at $692K in Q3 2024. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Acadian Asset Management reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • Acadian Asset Management sold 240 Insmed shares in Q2 2026, an estimated $39K.
  • Acadian Asset Management first reported a position in Insmed in Q3 2024 and held it in 7 quarters.
  • Acadian Asset Management's Insmed position peaked at $692K in Q3 2024.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.